glp 1 with kaiser insurance IBX members face GLP-1 drug costs after change The GLP-1 Access Gap: Mapping

Improvements in Sleep Apnoea: For individuals with obesity-related obstructive sleep apnoea (OSA), the significant weight loss often achieved with these medications can lead to notable improvements in OSA symptoms and severity

In the UK, NICE recommends GLP-1 receptor agonists for type 2 diabetes in specific circumstances (NG28), such as when metformin is insufficient and BMI 30 kg/m

Newer research suggests the muscle loss concern may have been overstated in some early studies

The best time depends on your schedule, meal patterns, and how your body handles the medication

doi:10.2337/dc24-S004 Watanabe JH, Kwon J, Nan B, Reikes A

The guide on switching from tirzepatide to semaglutide covers the logistics and expectations